(Lasmiditan)
Reyvow is not currently listed on the FDA drug shortage list. Medfinder's availability score is 1% (Very Difficult to Find), based on 70 pharmacy checks in the last 30 days. 6 patients have searched for Reyvow in the last 30 days. Last verified June 11, 2026, 8:01 AM ET.
Generated by Medfinder AI using proprietary data alongside publicly available data from the FDA and other sources.
Availability Score
Percentage of Medfinder pharmacy checks over the last 30 days that found this drug in stock. Calculated as in-stock reports ÷ total reports.1%(Very Difficult to Find)
FDA Status
Not ListedWe've helped 1 patients find Reyvow in stock over the last month.
Current public availability signals for Reyvow, recomputed every 6 hours from Medfinder pharmacy checks and FDA shortage records.
| Last verified | |
|---|---|
| Refresh cadence | Every 6 hours |
| Reporting window | Last 30 days |
| FDA status | Not listed |
| Availability score | 1% (Very Difficult to Find) |
| Pharmacy checks | 70 checks in the last 30 days |
| Patient reports | 6 |
| In-stock rate | 1% |
| Last in-stock report | 6/9/2026 |
| Methodology | How Medfinder verifies shortage and availability data |
Patient Shortage Reports
6
Total Pharmacies Checked
70
In Stock Percentage
1%
Total patient shortage reports for this medication over the last 8 weeks.
| Dosage | Total Pharmacies Checked | Change | Last Located | In Stock Percentage |
|---|---|---|---|---|
Get access to real-time availability data by region, pharmacy, and dosage — updated daily from thousands of pharmacy checks.
Summarized by Medfinder AI
FDA Status
N/AStart Date
N/AGet a weekly email with the latest drug shortage updates, resolutions, and availability changes.
We have a 99% success rate finding medications, even during nationwide shortages. Let us do the searching for you.
